Researchers and clinicians face ethical and policy-based challenges in disclosing, preventing and treating psychosis. Which diagnostic labels should be considered to motivate more effective public and professional dialogue about psychosis risk?
AMA J Ethics. 2016;18(6):624-632. doi:
10.1001/journalofethics.2016.18.6.msoc1-1606.
Neuroscience's associations between localized brain activity and specific cognitive tasks is not sufficient evidence for rejecting the notion of free will and absolving individuals of responsibility for their behavior.
Health care professionals have a responsibility to educate patients about public screening programs and ensure that subsequent follow-up is done after the screening is completed.